A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.

NCT07375758 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunoglobulin A Nephropathy

Interventions

DRUG: MIL116
DRUG: Matching Placebo

Sponsor

Beijing Mabworks Biotech Co., Ltd.